The Oncology Institute, Inc. TOI Other Commercial Liabilities
Other Commercial Liabilities at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s other commercial liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s other commercial liabilities?
- The Oncology Institute, Inc. (TOI) reported other commercial liabilities of $24.3M in Q1 2026.
- How has The Oncology Institute, Inc.'s other commercial liabilities changed year-over-year?
- The Oncology Institute, Inc.'s other commercial liabilities increased by 3.7% year-over-year, from $23.43M to $24.3M.
- What is the long-term trend for The Oncology Institute, Inc.'s other commercial liabilities?
- Over 5 years (2020 to 2025), The Oncology Institute, Inc.'s other commercial liabilities has grown at a 16.9% compound annual growth rate (CAGR), from $9.45M to $20.64M.